Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.
Wake Forest University Health Sciences
Eastern Cooperative Oncology Group
Atara Biotherapeutics
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Northwestern University
Roswell Park Cancer Institute
Bioniz Therapeutics
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Roswell Park Cancer Institute
University of Chicago
Fred Hutchinson Cancer Center
Swiss Cancer Institute
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Children's Oncology Group
Wake Forest University Health Sciences
German CLL Study Group
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Morphotek
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Indiana University
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Boston Medical Center
National Cancer Institute (NCI)